Stephane Imbert

Entrepreneur & Investor (Metaverse and MedTech)

📍 France🔄 Updated September 2026💼 4 investments📅 5 years investing🗓 Last invested May 2022
Operator-angel🌍 France
4
Total investments
0
Early stage
3
Mid stage
0
Late stage
5y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Board member
May 2022
DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, and proprietary deep learning-based cell engineering tools. Our goal is to supplement in vitro testing with in silico simulations and rapidly discover molecular triggers to efficiently engineer cell behavior. We are working closely with biotech and pharmaceutical companies to accelerate their target identification processes. We are also collaborating actively with the academic community by publishing papers and providing open access to our platform’s features and data.
mid stageBiotechnology
Investor & Board member
Mar 2022
Robeauté is pioneering a new class of therapeutic microrobots—engineered to diagnose, treat and monitor the brain with unprecedented flexibility and precision. We are a pluridisciplinary and multicultural team of passionate, supportive and creative people, at the crossroads of microrobotics, engineering and medicine. We are team players, with both classical and atypical backgrounds, so unconventional thinking is welcome and good communication skills are a must. Our team is growing and we are constantly on the lookout for incredible talent and grit. We are based in Paris, France. Check out our open roles: https://apply.workable.com/robeaute/ Follow us here as we tell you more of what we do.
Investor
Feb 2022
TemmaCare becomes AuxaSphere with new services. Join us at Auxasphere. Medicscopy enables a doctor to remotely view and observe a patient in real time using different secure medical connected devices
Investor & Board member
Dec 2021
UVR was created in 2017 to give designers and engineers a more efficient, reliable, and cost-effective way to build, test, and refine multiple prototypes and mock-ups in an interactive way. By combining years of experiences in large industries and scientific research, we developed cutting edge optical simulation software offering physics-based rendering, integrated with virtual reality. Our Mission To help you get the most out of your 3D CAD models by offering you next generation predictive appearance software. UVR lets you turn any 3D CAD model into true-to-life digital modelling, allowing you to reduce the need for physical prototypes and mock-ups in the design process.
Experience · 6 entries
All (6)
Investments (4)
Founder (2)
Board (3)
2022
Investor & Board member
May 2022
DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, and proprietary deep learning-based cell engineering tools. Our goal is to supplement in vitro testing with in silico simulations and rapidly discover molecular triggers to efficiently engineer cell behavior. We are working closely with biotech and pharmaceutical companies to accelerate their target identification processes. We are also collaborating actively with the academic community by publishing papers and providing open access to our platform’s features and data.
mid stageBiotechnology
Investor & Board member
Mar 2022
Robeauté is pioneering a new class of therapeutic microrobots—engineered to diagnose, treat and monitor the brain with unprecedented flexibility and precision. We are a pluridisciplinary and multicultural team of passionate, supportive and creative people, at the crossroads of microrobotics, engineering and medicine. We are team players, with both classical and atypical backgrounds, so unconventional thinking is welcome and good communication skills are a must. Our team is growing and we are constantly on the lookout for incredible talent and grit. We are based in Paris, France. Check out our open roles: https://apply.workable.com/robeaute/ Follow us here as we tell you more of what we do.
Investor
Feb 2022
TemmaCare becomes AuxaSphere with new services. Join us at Auxasphere. Medicscopy enables a doctor to remotely view and observe a patient in real time using different secure medical connected devices
2021
Investor & Board member
Dec 2021
UVR was created in 2017 to give designers and engineers a more efficient, reliable, and cost-effective way to build, test, and refine multiple prototypes and mock-ups in an interactive way. By combining years of experiences in large industries and scientific research, we developed cutting edge optical simulation software offering physics-based rendering, integrated with virtual reality. Our Mission To help you get the most out of your 3D CAD models by offering you next generation predictive appearance software. UVR lets you turn any 3D CAD model into true-to-life digital modelling, allowing you to reduce the need for physical prototypes and mock-ups in the design process.
2017
Founder & Executive Chairman - Acquired by Unity Technologies
Feb 2017
Now a part of @Unity3D Pixyz is the best-in-class solution for large 3D/CAD data automatic preparation, optimization & review, at scale. Based on first class tessellation algorithms and many others, our solutions help industrial companies and agencies re-use their 3D data for any visualization scenario, saving them time, effort and maximizing visualization performance. Pixyz aims at connecting 3D data to people, by bridging the gap between industrial CAD data and popular 3D platforms: WebGL, Unity, Unreal Engine... With Pixyz, your engineering CAD data can now directly serve different domains such as marketing, sales, design, maintenance, training, simulation, BIM...
Show all 6 entries ↓
Investment activity
2021–2022 · 4 investments
2021120223
Recent (last 2 years)Earlier